SAN RAMON, Calif., March 5, 2020—To enable eye care professionals to address their astigmatic patients’ evolving presbyopic needs, CooperVision, Inc. has announced the availability of its new Biofinity® toric multifocal contact lenses. The company has begun initial shipments of the highly anticipated lenses, with nationwide availability expected in May.
The latest addition to CooperVision’s flagship Biofinity® family of lenses combines the comfort and proven optical designs of Biofinity® toric—the #1 toric lens on the market1—and Biofinity® multifocal, which has also earned the trust of eye care professionals and wearers alike. Like all Biofinity® silicone hydrogel lenses, Biofinity® toric multifocal features CooperVision’s Aquaform® Technology, which offers superb breathability and higher moisture content to keep eyes comfortable and healthy.
“Correcting for astigmatism and presbyopia in a single contact lens is complex, and through our partnerships with eye care professionals, we have come to understand the challenges associated with fitting toric multifocal lenses,” said Michele Andrews, OD, Senior Director, Professional and Academic Affairs, North America, CooperVision. “With Biofinity® toric multifocal, all of that has changed; our advanced optical design and effective fitting guide have raised the bar. Prior to the introduction of this lens, wearers with astigmatism had to make compromises as they became presbyopic, but now we can offer the visual quality they have been looking for.”
CooperVision’s made-to-order advantage results in more than 200,000 unique Biofinity® toric multifocal prescription options2—46x more than ULTRA® Multifocal for Astigmatism3—ensuring that eye care professionals have the lens they need for each individual patient, resulting in the right fit, the first time. In fact, studies of Biofinity® toric multifocal showed a 93% success rate on initial fitting when using the fitting guide.4 And with 37% of toric lens wearers5 nearing or already experiencing presbyopia, the lens offers practitioners significant opportunity to successfully fit more astigmatic presbyopes in contact lenses.
Biofinity® toric multifocal features a combination of two of CooperVision’s trusted technologies:
- Optimized Toric Lens Geometry™ provides the proven properties for high patient satisfaction, including uniform horizontal iso-thickness, an optimized ballast band design, a large toric optical zone, and a smooth continuous surface. Initial product research found that the stability and orientation of Biofinity® toric multifocal is equivalent to Biofinity® toric.6
- Balanced Progressive® Technology offers multiple zones of vision correction, allowing for exceptional vision at near distance, far away, and in between. It is optimized for each sphere and add power, with the option of fitting a center D or center N lens.
“As the market leader in toric contact lenses7, our customers have called on CooperVision to develop a lens to help them successfully transition their astigmatic patients into their presbyopic years,” said Dr. Andrews. “We are proud to introduce Biofinity® toric multifocal to address that need.”
Biofinity® toric multifocal lenses are available in sphere powers from +10.00 to -10.00 (0.50 steps after +/-6.00D), with cylinder powers from -0.75 to -5.75 (0.50 steps), an axis of 5 degrees to 180 degrees in 5-degree steps, and add powers of +1.00, +1.50, +2.00, and +2.50.
For more information, visit https://coopervision.com/practitioner/only-biofinity-toric-multifocal.
# # #
* Assessed approximately 1 hour post-insertion
1 CVI data on file, 2019. US industry reports and internal estimates. Toric fit data.
2 CVI data on file 2019. Based on total number of prescription option combinations manufactured (for sphere, cylinder, axis and add – including D & N combinations).
3 CVI data on file 2019. Bausch + Lomb product specifications, U.S. Oct 2019. Based on total number of prescription option combinations manufactured (for sphere, cylinder, axis and add – including D & N combinations; Biofinity® toric multifocal is made-to-order; ULTRA® Multifocal for Astigmatism is stocked).
4 CVI Data on file 2018. Non-dispensing, subject masked, randomized, bilateral, cross-over short-term clinical evaluation. 27 astigmatic, presbyopic soft CL wearers at 2 sites (UK & US) fitted using CVI fit guide.
5 CVI data on file, 2019, U.S., Industry reports and internal estimates of toric contact lenses from 4 main manufacturers.
6 CVI data on file 2019. Sub-analysis of lens orientation on settling with BT & BTMF. N=89.
7 CVI data on file, 2019. US industry reports and internal estimates. Based on monthly toric fit data.
ULTRA® Multifocal for Astigmatism is a registered trademark of Baush + Lomb
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies (“Cooper”) is a global medical device company public traded on NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
McDougall Communications for CooperVision, Inc.
email@example.com or +1-585-434-2148